Alzamend Neuro, Inc. (ALZN)

Alzamend Neuro Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Year Ending	TTM	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019
Cash & Equivalents	0.28	5.14	14.06	1.93	0.09	0.04
Cash & Short-Term Investments	0.28	5.14	14.06	1.93	0.09	0.04
Cash Growth	-96.16%	-63.45%	628.97%	2036.87%	111.91%	-92.18%
Receivables	-	-	-	0.02	0.19	0.29
Prepaid Expenses	0.31	0.69	0.35	0.97	1.53	1.17
Total Current Assets	0.59	5.84	14.41	2.91	1.81	1.5
Property, Plant & Equipment	0.19	0.08	0.1	-	-	-
Total Assets	0.78	5.92	14.52	2.91	1.81	1.5
Accounts Payable	3.83	2.87	1.16	0.5	0.93	1.1
Short-Term Debt	-	-	-	0.34	0.06	0.08
Other Current Liabilities	-	-	0	0.06	-	-
Total Current Liabilities	3.83	2.87	1.16	0.9	0.99	1.18
Other Long-Term Liabilities	0.74	-	-	-	-	-
Total Liabilities	4.57	2.87	1.16	0.9	0.99	1.18
Common Stock	0	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	48.97	61.99	57.42	33.72	27.58	22.69
Retained Earnings	-53.17	-44.07	-29.19	-16.83	-11.79	-7.38
Comprensive Income & Other	-	-14.88	-14.88	-14.88	-14.98	-15
Total Common Equity	-4.19	3.05	13.35	2.01	0.82	0.32
Shareholders' Equity	-3.79	3.05	13.35	2.01	0.82	0.32
Total Liabilities & Equity	0.78	5.92	14.52	2.91	1.81	1.5
Total Debt	-	-	-	0.34	0.06	0.08
Net Cash (Debt)	0.28	5.14	14.06	1.59	0.03	-0.04
Net Cash Growth	-96.16%	-63.45%	782.32%	5671.48%	-	-
Net Cash Per Share	0.42	7.91	23.68	3.29	0.06	-0.09
Filing Date Shares Outstanding	0.69	0.65	0.64	0.57	0.43	0.42
Total Common Shares Outstanding	0.66	0.65	0.64	0.45	0.43	0.41
Working Capital	-3.23	2.97	13.25	2.01	0.82	0.32
Book Value Per Share	-6.34	4.71	20.97	4.48	1.90	0.77
Tangible Book Value	-4.19	3.05	13.35	2.01	0.82	0.32
Tangible Book Value Per Share	-6.34	4.71	20.97	4.48	1.90	0.77

Source: S&P Capital IQ. Standard template.